Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Posts Zero Q3 Revenue Though Losses Decline 30 Percent

NEW YORK (GenomeWeb News) — Compugen today reported zero revenues for the third quarter as net losses declined 30 percent.
 
Receipts for the three months ended Sept. 30, 2005, were $95,000, Compugen said.
 
R&D spending for the quarter declined 26 percent to $1.7 million from $2.3 million in 2005.
 
Compugen said net losses in the quarter declined 30 percent to $2.5 million  percent from $3.6 million year over year.  
 
At the end of the period the company held $22.5 million in cash, equivalents, and short-term deposits and marketable securities.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.